MoonLake Immunotherapeutics - 8-K Filing

MoonLake Immunotherapeutics submitted a BLA for sonelokimab to treat hidradenitis suppurativa. (Items: 8.01 Other Events)

SEC EDGAR ·

Tickers: $MLTX

Read the full article at SEC EDGAR

More Regulatory news